Seeking Alpha
29 Oct 2026, 05:51 UTC · 1h ago
Onterris: Buy A Broken Narrative, Not A Broken Business
Impact · against what's priced in
The article provides a bullish case for Onterris based on EBITDA recovery and potential M&A catalysts, but these elements are largely framed as expectations rather than new developments. The primary value lies in the identified path to deleveraging and the strategic review, which provide a concrete timeline for potential upside.
- ONT+0.40
No priced-in read yet
- In context
The adoption of a poison pill and a formal strategic review increase the likelihood of a control premium event, while the 2027 EBITDA target of $131 million provides a clear path to resuming buybacks.
Read from the article alone
